Search results
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 6 hours agoShares of Moderna (MRNA 2.41%) were sinking 9% lower this week as of Thursday's market close,...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 6 hours agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 13 hours ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
US government, Moderna nearing deal for bird flu vaccine funding: reports
The Hill via AOL· 9 hours agoThe U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 11 hours agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 8 hours agoModerna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine,...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 1 day agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 13 hours agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 16 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 1 day agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...